Free Trial
LON:SN

Smith & Nephew (SN) Share Price, News & Analysis

Smith & Nephew logo
GBX 1,122.50 -33.00 (-2.86%)
As of 07/11/2025

About Smith & Nephew Stock (LON:SN)

Key Stats

Today's Range
1,122.50
1,140
50-Day Range
1,056.50
1,124.50
52-Week Range
N/A
Volume
1.27 million shs
Average Volume
343,671 shs
Market Capitalization
£12.31 billion
P/E Ratio
40.41
Dividend Yield
2.58%
Price Target
GBX 7,840
Consensus Rating
Buy

Company Overview

Smith & Nephew Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
78th Percentile Overall Score

SN MarketRank™: 

Smith & Nephew scored higher than 78% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Smith & Nephew has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Smith & Nephew has received no research coverage in the past 90 days.

  • Read more about Smith & Nephew's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Smith & Nephew is 40.41, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Smith & Nephew is 40.41, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Earnings Growth Ratio

    Smith & Nephew has a PEG Ratio of 0.46. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Smith & Nephew has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for SN.
  • Dividend Leadership

    Smith & Nephew is a leading dividend payer. It pays a dividend yield of 3.66%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Smith & Nephew does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Smith & Nephew is 104.41%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Smith & Nephew's dividend.
  • Short Interest

    There is no current short interest data available for SN.
  • News Sentiment

    Smith & Nephew has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • Search Interest

    5 people have searched for SN on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Smith & Nephew to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Smith & Nephew insiders have bought more of their company's stock than they have sold. Specifically, they have bought £19,848.50 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    Only 0.19% of the stock of Smith & Nephew is held by insiders.

  • Percentage Held by Institutions

    62.24% of the stock of Smith & Nephew is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Smith & Nephew's insider trading history.
Receive SN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SN Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Smith & Nephew Stock Price History
See More Headlines

SN Stock Analysis - Frequently Asked Questions

Smith & Nephew's stock was trading at GBX 991.40 at the beginning of the year. Since then, SN stock has increased by 13.2% and is now trading at GBX 1,122.50.

Shares of SN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Smith & Nephew investors own include Imperial Brands (IMB), Smith & Nephew SNATS (SNN), Barclays (BARC), Lloyds Banking Group (LLOY), GSK (GSK), AstraZeneca (AZN) and Meta Platforms (META).

Company Calendar

Record date for 5/28 Dividend
3/27/2025
Ex-Dividend for 5/28 Dividend
3/27/2025
Dividend Payable
5/28/2025
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Consumer Goods
Current Symbol
LON:SN
CIK
N/A
Fax
N/A
Employees
18,452
Year Founded
N/A

Price Target and Rating

High Price Target
£145
Low Price Target
GBX 1,180
Potential Upside/Downside
+598.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 27.77
Trailing P/E Ratio
40.41
Forward P/E Ratio
12.08
P/E Growth
0.46
Net Income
£382.79 million
Net Margins
5.41%
Pretax Margin
N/A
Return on Equity
5.85%
Return on Assets
4.51%

Debt

Debt-to-Equity Ratio
70.22
Current Ratio
2.51
Quick Ratio
0.84

Sales & Book Value

Annual Sales
£7.08 billion
Price / Sales
1.74
Cash Flow
GBX 60.08 per share
Price / Cash Flow
18.68
Book Value
GBX 595.90 per share
Price / Book
1.88

Miscellaneous

Outstanding Shares
1,096,260,062
Free Float
N/A
Market Cap
£12.31 billion
Optionable
Not Optionable
Beta
0.62
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:SN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners